Navigation Links
Leading Global Clinical Research Organization chooses GBS to Support their IBM Domino Infrastructure
Date:7/29/2013

Woodstock, GA (PRWEB) July 29, 2013

GBS Enterprises Inc. (GBSX), a global software and services company specializing in Application Modernization, Mobility and Infrastructure Management announced that they have been chosen to support and maintain the IBM Domino and Notes infrastructure of one of the world’s leading clinical research firms.

The firm is known for its high performance and reputation for conducting global clinical development programs of the highest integrity. It is a leader in delivering clinical trial programs to pharmaceutical and biotechnology companies in therapeutic areas of specialty, and in innovative pediatric and women’s health trials.

With an increase in demand on critical IT resources it was an easy decision to choose GBS to manage their IBM Domino and Notes infrastructure.

“Organizations with IBM Notes and Domino infrastructure continue to have increased demand from users for improved infrastructure and support systems. Having internal IT staff spend time maintaining and supporting existing infrastructure is expensive, and as we are also hearing from many customers, prevents them from focusing on strategic and long term projects”, says Joerg Ott, CEO of GBS. “GBS’ Domino Admin Services offerings are tailored specifically for organizations running IBM Domino infrastructure to enable them to reduce cost, optimize performance and improve SLAs.”    

About GBS (GROUP Business Software)
GBS Enterprises Inc. (GBSX) is the world’s leading provider of expertise and solutions for the IBM Notes and Domino platform. GBS enables organizations with investments in Notes and Domino infrastructure to effectively respond to the rapidly evolving needs of their business users, while lowering costs and increasing returns on these investments. GBS helps customers understand and evaluate their cur-rent infrastructure and application environments, formulate strategic technology and operational goals, and implement solutions that meet current and future business needs.

GBS has over 5,000 customers with over 4 million users of its products and services. GBS resources are available at 12 locations across North America, Europe and Asia. For more information, please visit http://www.gbs.com.

Caution Concerning Forward-Looking Statements
This release contains statements that may constitute "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. These statements regard the intent, belief, and expectations of the Company. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, they involve risks and uncertainties, and their results may differ materially.

Media Contact:
Michael Baum, Corporate Communications
michael(dot)baum(at)us(dot)gbs(dot)com

Read the full story at http://www.prweb.com/releases/2013/7/prweb10971777.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Leading experts on congenital muscular dystrophy convene at University of Nevada, Reno
2. Diabetes drug could treat leading cause of blindness
3. Pneumonia and preterm birth complications are the leading causes of childhood death
4. Leading health care quality expert is 2012 AcademyHealth Distinguished Investigator
5. Dr. Edmund Lipskis & Dr. Lynn Lipskis Will be Featured On New National Television Show Entitled: “Leading The Field” World Class Experts Share Their Tips & Advice
6. ACR: Medical imaging study in health affairs incomplete and potentially misleading
7. Poorly-performing hand implants unacceptable says leading medical journal
8. Leading cancer specialists from Europe and beyond recognized at ESMO 2012
9. WSU researchers discover mechanism leading from trichomoniasis to prostate cancer
10. Report: Cancer now leading cause of death in US hispanics
11. Leading stem cell scientists to focus on diabetes, eye diseases at Cedars-Sinai symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
Breaking Medicine Technology: